Speakers
Prof. Xiaodong Cheng
“TCM in Cancer: Recent Progress in Animal Studies” (WP5).
School of Life Sciences and Technology, Director Laboratory of Cellular and Molecular Immunology, Director The TCM Great Master Training Program, Tongji University
Distinguished Professor, Yue-yang Hospital, Shanghai University of Traditional Chinese Medicine, Room 1112, Medicine Building,1239 Si-ping Road, Shanghai, 200092, P.R. China
AbstractProf. Wei Ding
“The sketch of clinical oriented acupuncture basic research in China based on literature analyses” WP8
Department of Biochem & Mol Biol, Capital Medical University, China
AbstractProf. Pierre Duez
“First-line toxicological models for genotoxicity and nephrotoxicity assessment of herbal products” WP3
Laboratoire de Pharmacognosie, de Bromatologie et de Nutrition Humaine, Service de Chimie Thérapeutique et de Pharmacognosie (UMons), L’Université Libre de Bruxelles, CP 205/9, Bd du Triomphe, 1050 Bruxelles, Belgium
AbstractProf. Tai-Ping Fan
Impact of omics on R&D and future regulation of complex plant-derived products including Chinese herbal medicines
Tai-Ping Fan1 and Olavi Pelkonen2
1Angiogenesis and Chinese Medicine Laboratory, Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, United Kingdom [tpf1000@cam.ac.uk]; 2Department of Pharmacology and Toxicology, University of Oulu, 90014 Oulu, Finland
AbstractProf. Dr. em. Gerhard Franz
“Current problems and possible solutions when establishing TCM-Herbal Drug Monographs for the European Pharmacopoeia!”
Dept. of Pharmacy, University of Regensburg, Universitätsstr. 31, D- 93040 Regensburg /Germany, Chairman of the EP-Commission TCM Working Party
AbstractProf. Dr. Jan van der Greef
“A systems biology view on Health and Disease, integrating Western and Chinese perspectives”
Sino-Dutch centre for Preventive and Personalized Medicine, TNO and Leiden university, The Netherlands.
AbstractProf. Peter Hylands
“An overview of the use of omics in TCM research” WP4
Professor of Pharmaceutical Chemistry, and Joint Head of Institute of Pharmaceutical Science, and Head, Department of Pharmacy, King’s College London, Franklin-Wilkins Building 150, Stamford StreetLondon SE1 9NH
AbstractDr. Werner Knöss
“TCM - Options and Perspectives in the European Regulatory Framework for Medicinal Products”
Head of Department Complementary and AlternativeMedicines and Traditional MedicinesFederal Institute for Drugs and Medical DevicesKurt-Georg-Kiesinger-Allee 3, D-53175 Bonn, Germany; Chair HMPC, European Medicines Agency (EMA), London
AbstractDr. Shwu-Huey Liu
“R&D and clinical trial of PHY906 in the USA”
Shwu-Huey Liu1 , Zaoli Jiang1, Robert Tilton1, Wing Lam2, Wei Zhang2 and Yung-Chi Cheng2
1PhytoCeutica Inc., Branford, CT 06405, USA.
2Yale University School of Medicine, New Haven, CT 06510, USA.
AbstractProf. Nicola Robinson
“The evidence challenge for GP-TCM”
Professor of Traditional Chinese Medicine (TCM) and Integrated Health, Allied Health Sciences, Faculty of Health and Social Care, London South Bank University, 103 Borough Road, London SE1 0AA, UK
AbstractDr. Jandirk Sendker
“Extraction and Component Analysis of Chinese Herbal Medicines”
Institute of Pharmaceutical Biology and Phytochemistry, Hittorfstrasse 56, D-48149 Münster, GermanyProf. Monique Simmonds: WP1
Prof. Claudia Witt
“The efficacy-effectiveness continuum in clinical research - implications for TCM research”
Professor of MedicineCarstens Foundation Distinguished Professor for Complementary Medicine ResearchVice DirectorInstitute for Social Medicine, Epidemiology and Health EconomicsCharité Universitätsmedizin Berlin, Luisenstr. 57, 10117 Berlin, Germany
AbstractDr. Youping Zhu
“Chinese herbal industry: Fragmentation in a globalized world”
CMC Tasly Group, Amsterdam, The Netherlands.
Abstract
